Albireo Pharma (ALBO) is Initiated by Ladenburg Thalmann to “Buy” - Highland Mirror

Highland Mirror
Albireo Pharma (ALBO) is Initiated by Ladenburg Thalmann to “Buy”
Highland Mirror
Albireo Pharma (ALBO) was Initiated by Ladenburg Thalmann to “Buy” and the brokerage firm has set the Price Target at $40. Ladenburg Thalmann advised their Clients and Investors in a research report released on Feb 16, 2017. Albireo Pharma closed ...
A report released today by Ladenburg Thalmann about Albireo Pharma ...Breaking Finance NewsAlle 5 Artikel »